Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The cJun N-terminal kinases (JNKs; JNK1, JNK2, and JNK3) promote degenerative processes after neuronal injury and in disease. JNK2 and JNK3 have been shown to promote retinal ganglion cell (RGC) death after optic nerve injury. In their absence, long-term survival of RGC somas is significantly increased after mechanical optic nerve injury. In glaucoma, because optic nerve damage is thought to be a major cause of RGC death, JNKs are an important potential target for therapeutic intervention. To assess the role of JNK2 and JNK3 in an ocular hypertensive model of glaucoma, null alleles of Jnk2 and Jnk3 were backcrossed into the DBA/2J (D2) mouse. JNK activation occurred in RGCs following increased intraocular pressure in D2 mice. However, deficiency of both Jnk2 and Jnk3 together did not lessen optic nerve damage or RGC death. These results differentiate the molecular pathways controlling cell death in ocular hypertensive glaucoma compared with mechanical optic nerve injury. It is further shown that JUN, a pro-death component of the JNK pathway in RGCs, can be activated in glaucoma in the absence of JNK2 and JNK3. This implicates JNK1 in glaucomatous RGC death. Unexpectedly, at younger ages, Jnk2-deficient mice were more likely to develop features of glaucomatous neurodegeneration than D2 mice expressing Jnk2. This appears to be due to a neuroprotective effect of JNK2 and not due to a change in intraocular pressure. The Jnk2-deficient context also unmasked a lesser role for Jnk3 in glaucoma. Jnk2 and Jnk3 double knockout mice had a modestly increased risk of neurodegeneration compared with mice only deficient in Jnk2. Overall, these findings are consistent with pleiotropic effects of JNK isoforms in glaucoma and suggest caution is warranted when using JNK inhibitors to treat chronic neurodegenerative conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“haploinsufficiency of JNK2, or both JNK2 and JNK3, results in an increase in ocular hypertension-induced neurodegeneration”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [130]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“suggesting JNK2 as a potential tool for glaucoma treatment [ 130 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Selective interaction of JNK protein kinase isoforms with transcription factors.
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,338
Burgoyne, C. F., Crawford Downs, J., Bellezza, A. J., Francis Suh, J.-K., & Hart, R. T. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.001 · Cited by 1,140
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., & Davis, R. J. (2013) · Science · doi:10.1126/science.1227568 · Cited by 636
Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice
Williams, P. A., Harder, J. M., Foxworth, N. E., Cochran, K. E., Philip, V. M., Porciatti, V., Smithies, O., & John, S. W. M. (2017) · Science · doi:10.1126/science.aal0092 · Cited by 617
Self-citationEssential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
John, S. W. M., Smith, R. S., Savinova, O. V., Hawes, N. L., Chang, B., Turnbull, D., Davisson, M. T., Roderick, T. H., & Heckenlively, J. R. (1998) · PubMed · Cited by 603
Self-citationAxons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma
Howell, G. R., Libby, R. T., Jakobs, T. C., Smith, R. S., Phalan, F. C., Barter, J. W., Barbay, J. M., Marchant, J. K., Mahesh, N., Porciatti, V., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706181 · Cited by 596
Self-citationHowell, G. R., Macalinao, D. G., Sousa, G. L., Walden, M., Soto, I., Kneeland, S. C., Barbay, J. M., King, B. L., Marchant, J. K., Hibbs, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44646 · Cited by 473
Self-citationEffect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve.
Anderson, D. R., & Hendrickson, A. E. (1974) · PubMed · Cited by 469
Research works printed but not linked: 1
- Smith R. S. et al. in Systemic evaluation of the mouse eye (ed Smith R. S.) 265-297 (CRC Boca Raton, Florida Press, 2002).
Cited by
Tezel, G. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100998 · Cited by 163
Axon injury signaling and compartmentalized injury response in glaucoma
Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.002 · Cited by 99
Self-citationMAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“On the other side of the spectrum, haploinsufficiency of JNK2, or both JNK2 and JNK3, results in an increase in ocular hypertension-induced neurodegeneration, suggesting JNK2 as a potential tool for glaucoma treatment [130].”
BackgroundZhao, W., Fan, C.-L., Hu, X., Ban, X.-X., Wan, H., He, Y., Zhāng, Q., & Xiong, K. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01373-1 · Cited by 46
Metadata
- Authors
- Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M.
- Affiliations
- Jackson Laboratory (US)
- Rowan University (US)
- University of Rochester Medicine (US)
- Tufts University (US)
- Corresponding author
- Libby, Richard T.
- John, Simon. W. M.
- ORCID
- Venue
- Cell Death & Disease
- Published
- 2018-06-13
- Volume
- 9
- Issue
- 6
- Pages
- 705-705
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC6000001
- OpenAlex
- W2808390585
- Cited by
- 23
- References
- 47
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- Research to Prevent Blindness
- Glaucoma Foundation
- University of Rochester
- Partridge Foundation
- Medical Center, University of Rochester
- National Eye Institute (R01EY027701, R01EY018606)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007065)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- JNK2, JNK3, JNK1, glaucoma, retinal ganglion cell death, ocular hypertension, DBA/2J mice, c-Jun, neurodegeneration, intraocular pressure, optic nerve injury, JNK inhibitor, neuroprotection
- MeSH terms
- Animals, Axons, Enzyme Activation, Gene Expression Regulation, Glaucoma, Intraocular Pressure, Mice, Inbred DBA, Nerve Degeneration, Ocular Hypertension, Optic Nerve, Retina, Retinal Ganglion Cells, Cell Death, Mitogen-Activated Protein Kinase 9, Mitogen-Activated Protein Kinase 10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. https://app.cochat.ai/papers/10.1038/s41419-018-0705-8
- The paper
- Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M. (2018). Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0705-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.